GENELUX CORPORATION COMMON STOCK reports a Return on Equity (ROE) of -138.64%.

What is GNLX's dividend yield?

GENELUX CORPORATION COMMON STOCK offers a dividend yield of 0.00%.

What is GNLX's Deepscope Quality Score?

Deepscope rates GNLX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy GNLX?

Deepscope's AI Timing Score for GNLX is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does GNLX belong to?

GENELUX CORPORATION COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

GNLX (NASDAQ) 株価分析 | GENELUX CORPORATION COMMON STOCK

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-18 | FS: 2026-03-31)

GNLX

GENELUX CORPORATION COMMON STOCK

US:NASDAQ STOCK Healthcare >> Biotechnology News 70

USD 2.97

0.12 (4.04%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-138.6%

ROE

-98.2%

ROA

0.00%

Div Yield

GENELUX CORPORATION COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.97 Price 0.12 (4.04%) Day Change	NEWS SCORE: 70

GNLX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	70
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.97
PBV / Sector	5.58 / 4.92
Earning Per Share	-0.74

PE / Sector	N/A / 18.37
PEG or PE/Growth / Sector	N/A / 0.60
Average 1M Daily Value	0.49 M GREAT
Average 1W Daily Value	0.62 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-397,225.00 / 468.85
NPM Average (%) / Sector	-237,818.47 / -1,531.69
NPM Change Average (%) / Sector	9,357.69 / 5,028.65 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-98.17 / 31.69
ROA Average (%) / Sector	-109.75 / -353.18
ROA Change Average (%) / Sector	11.76 / 5,214.65 GOOD
ROE (%) / Sector	-138.64 / 10.58
ROE Average (%) / Sector	-132.31 / 27.64
ROE Change Average (%) / Sector	-256.41 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

登録情報

Analyze Date	2026-06-19 09:46:55
Symbol	GNLX
Name	GENELUX CORPORATION COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	44.84 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	127.80 / 9,037.72

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2625 Townsgate Road, Westlake Village, CA, United States, 91361

Phone: 805 267 9889

Website: https://www.genelux.com

Sector: Healthcare >> Biotechnology

Description: Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.